ACST: Acasti Pharma Inc. - Summary | Jitta

Acasti Pharma Inc.

CAN:ACST

Notice
Stock data is unavailable or the company’s delisted.
Price
CA$0.58
Loss Chance
58.2%
0.61JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (14)
Recent Business Performance (11)
Financial Strength (47)
Return to Shareholders (0)
Competitive Advantage (9)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.61
100.00%
2.13
70.28%
2.40
107.49%
Pharmaceuticals
4.12
84.24%
4.12
84.24%
3.07
345.14%
COMPANY DESCRIPTION
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.